Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
Running, not enrolling · Not applicable
Conditions studied: Cancer, Diabetes
In brief
To test the use of a continuous activity and heart rate tracker (Fitbit) and continuous glucose monitor (CGM) in monitoring daily exercise-related activities.
Key facts
- Study ID
- NCT05124405
- Run by
- M.D. Anderson Cancer Center
- People needed
- 35
- Starts
- 2018-05-24
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2026-05-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women at least 18 years old
- Body mass index (BMI) 25 kg/m2
- Engage in less than 150 minutes of moderate-intensity PA per week in the past month
- Capable of participating in moderate-vigorous unsupervised exercise (as determined by the Physical Activity Readiness Questionnaire (PARQ) or a medical release from their physician)
- Self-reported ability to walk one block without pain or discomfort
- Have a smart phone with daily internet access that is compatible with the LibreLink app
- Ability to speak, read, and write in English
- For the cancer survivor cohort (participant accession number #21 and beyond), individuals must have been diagnosed with stage I-III breast or colorectal cancer and completed adjuvant therapy (i.e., chemo and/or radiation therapy).
You may not qualify if…
- Self-reported current diagnosis or history of type 1 diabetes or type 2 diabetes
- Self-reported use of oral antidiabetic agents (OADs)
- Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator)
- Current use of a continuous glucose monitor
- Fasting glucose > 125 mg/dL
- Pregnancy
- Self-reported health issues that limit physical activity
- On dialysis
- Work overnight shifts
- Unwilling to use CGM
- Current participation in other wellness or weight loss-related program or intervention
- Currently on a low-carb diet
- Unable to receive REDCap survey through their mobile phones
Where it is running
- M D Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.